A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)
Clinical trial NCT03463876 · COMPLETED
Trial details
- NCT number
- NCT03463876
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-08
- Primary completion
- 2021-03-10
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.